PAGNIN, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 5.458
AS - Asia 1.512
EU - Europa 1.059
SA - Sud America 312
AF - Africa 277
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.658
Nazione #
US - Stati Uniti d'America 5.318
SG - Singapore 492
CN - Cina 375
HK - Hong Kong 307
BR - Brasile 214
DE - Germania 162
IT - Italia 147
FI - Finlandia 120
SE - Svezia 87
UA - Ucraina 70
GB - Regno Unito 68
VN - Vietnam 67
FR - Francia 49
NL - Olanda 47
RU - Federazione Russa 39
PL - Polonia 38
IN - India 26
AT - Austria 23
TR - Turchia 22
AR - Argentina 21
ES - Italia 19
CA - Canada 16
BW - Botswana 15
IE - Irlanda 15
ZA - Sudafrica 15
EC - Ecuador 14
CG - Congo 13
ID - Indonesia 13
AE - Emirati Arabi Uniti 12
AL - Albania 12
BO - Bolivia 12
CH - Svizzera 12
GT - Guatemala 12
CI - Costa d'Avorio 11
GR - Grecia 11
HN - Honduras 11
ML - Mali 11
MX - Messico 11
MY - Malesia 11
SI - Slovenia 11
BD - Bangladesh 10
CO - Colombia 10
EG - Egitto 10
GF - Guiana Francese 10
GH - Ghana 10
IQ - Iraq 10
PA - Panama 10
ZW - Zimbabwe 10
AO - Angola 9
DO - Repubblica Dominicana 9
LV - Lettonia 9
NP - Nepal 9
PT - Portogallo 9
RO - Romania 9
RS - Serbia 9
VE - Venezuela 9
AZ - Azerbaigian 8
CD - Congo 8
CZ - Repubblica Ceca 8
HT - Haiti 8
IL - Israele 8
KH - Cambogia 8
KR - Corea 8
KZ - Kazakistan 8
SD - Sudan 8
SN - Senegal 8
AU - Australia 7
CV - Capo Verde 7
DK - Danimarca 7
DZ - Algeria 7
ET - Etiopia 7
GN - Guinea 7
HR - Croazia 7
IS - Islanda 7
LT - Lituania 7
LU - Lussemburgo 7
MA - Marocco 7
MU - Mauritius 7
NE - Niger 7
NZ - Nuova Zelanda 7
PE - Perù 7
PH - Filippine 7
SA - Arabia Saudita 7
SO - Somalia 7
TH - Thailandia 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
YE - Yemen 7
AM - Armenia 6
BF - Burkina Faso 6
BG - Bulgaria 6
BY - Bielorussia 6
BZ - Belize 6
CU - Cuba 6
CY - Cipro 6
DJ - Gibuti 6
GA - Gabon 6
GP - Guadalupe 6
IR - Iran 6
Totale 8.408
Città #
Fairfield 879
Houston 476
Ashburn 473
Chandler 428
Woodbridge 411
Seattle 337
Wilmington 312
Cambridge 310
Hong Kong 297
Singapore 291
Jacksonville 259
Ann Arbor 197
Boardman 116
Princeton 115
Beijing 95
Santa Clara 80
San Diego 70
Roxbury 57
Nanjing 52
Helsinki 50
Munich 41
Dong Ket 34
Medford 34
New York 34
Guangzhou 30
Los Angeles 28
Bytom 27
Des Moines 27
Padova 23
São Paulo 22
Nanchang 18
Hefei 14
Vienna 14
Istanbul 13
Jinan 13
Turku 13
Dublin 12
London 12
Gaborone 11
Ho Chi Minh City 11
Abidjan 10
Bamako 10
Buffalo 10
Council Bluffs 10
Harare 10
Panama City 10
Changsha 9
Dallas 9
Luanda 9
Nuremberg 9
Accra 8
Brazzaville 8
Dakar 8
Jiaxing 8
Norwalk 8
Riga 8
Shanghai 8
Tirana 8
Addis Ababa 7
Baku 7
Cayenne 7
Chennai 7
Conakry 7
Shenyang 7
Taizhou 7
Tashkent 7
Warsaw 7
Atlanta 6
Baghdad 6
Charlotte 6
Frankfurt am Main 6
Hanoi 6
Havana 6
Kampala 6
Kharkiv 6
Kigali 6
Kuala Lumpur 6
Libreville 6
Managua 6
Niamey 6
Ogden 6
Reykjavik 6
Sanaa 6
Tianjin 6
Ulan Bator 6
Zagreb 6
Zhengzhou 6
Amman 5
Apia 5
Bishkek 5
Borås 5
Boston 5
Brasília 5
Djibouti 5
George Town 5
Guatemala City 5
Hebei 5
Johannesburg 5
Kathmandu 5
Khartoum 5
Totale 6.144
Nome #
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 229
Searching for an additional treatment to slowing the progression of Fabry disease 189
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 184
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 182
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 178
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 177
Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle 176
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement? 169
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 166
Co-stimulatory modulation in rheumatoid arthritis: The role of (CTLA4-Ig) abatacept 165
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 165
Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro. 159
Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways 155
Comment on “Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis” by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018 150
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 149
Is heme oxygenase-1 turning out to be a key positive regulator for oxidative stress? 147
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 146
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 142
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 140
The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing 134
At the crossroads of longevity and metabolism: The metabolic syndrome and lifespan determinant pathways 133
Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism. 132
Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients 132
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes 130
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. 129
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 129
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients 129
P1190 Oxidative stress and inflammation in peritoneal dialysis: dangerous and to be solved. 128
Abnormalities of Gq-mediated cell signaling in Bartter's and Gitelman's syndome 127
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. 127
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 126
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II 122
Endothelial dysfunction in type 2 diabetes mellitus. 122
Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression 121
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 119
Analysis of Gq protein alpha subunit mRNA expression in human monocytes: relevance of the purification step 115
Effects of androgens on endothelial progenitor cells in vitro and in vivo 115
Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. 115
Oxidative stress and profibrotic action of aldosterone 111
Specific effect of arachidonic acid on inducible nitric oxide synthase mRNA expression in human osteoblastic cells 108
Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension 105
Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension 105
Antioxidant effect of L-carnitine and its short chain esters - Relevance for the protection from oxidative stress related cardiovascular damage 102
Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: Relationship with oxidative stress 96
Cardiac dysfunction in Bartter's and Gitelman's syndromes 95
Early markers of inflammation in a high angiotensin II state - results of studies in Bartter's/Gitelman's syndromes 95
Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes 95
Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection. 94
PLC beta 1-SHP-2 complex, PLC beta 1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling? 94
Effect of doxazosin on oxidative stress related proteins in essential hypertensive patients 93
Hemodiafiltration With Online Regeneration of Ultrafiltrate: Effect on Heme-Oxygenase-1 and Inducible Subunit of Nitric Oxide Synthase and Implication for Oxidative Stress and Inflammation 92
Tracing Angiotensin II's Yin -Yang effects on cardiovascular-renal pathophysiology. Yin and yang systems of Ang II. 91
Rho/Rho-kinase and C-reactive protein relationship in hypertension and atherosclerosis 88
The search for a link between inflammation and hypertension - contribution from Bartter's/Gitelman's syndromes 87
Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril 87
Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome. 87
Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling 84
Effect of manidipine on gene expression and protein level of oxidative stress-related proteins: p22(phox) and HO-1 - Relevance for antihypertensive and anti-remodeling effects 82
NADPH oxidase, superoxide overproduction and nitric oxide bioavailability in essential hypertension 81
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 80
Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension. 79
Arterial hypertension and oxidative stress induced by cyclosporin. Effect of carvedilol 79
Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity. 79
Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling 78
Insulin signaling, glucose metabolism, and the angiotensin II signaling system - Studies in Bartter's Gitelman's syndromes 75
Rho kinase activity and atrial fibrillation: insights fromchronic kidney disease and dialysis patients. 72
Angiotensin II long-term signaling in Bartter's/Gitelman's syndrome. Relevance for hypertension and cardiovascular remodeling 70
Effect of epoetin on oxidative stress in hemodialysis. A molecular biologic approach 68
Kidney transplant in Gitelman's syndrome. Report of the first case. 64
Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine 64
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course 62
L'effetto ipotensivo del carvedilolo nell'ipertensione del post-trapianto si associa a riduzione dello stress ossidativo e della fibrogenesi. Ruolo di NO, O2- e TGFbeta 61
The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion 60
Rho kinase and PAI-1 in Bartter/Gitelman syndromes. Relationship to angiotensin II signaling 56
Role of insulin-like growth factor-1 in primary osteoporosis: a correlative study 56
Oxidative stress and nitric oxide system in post-transplant hypertension 55
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis 45
Totale 8.728
Categoria #
all - tutte 30.801
article - articoli 29.960
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021824 0 0 27 78 41 85 42 84 131 138 91 107
2021/20221.031 17 124 128 84 45 67 63 118 43 17 115 210
2022/2023783 151 96 22 127 111 89 0 54 84 9 30 10
2023/2024399 25 58 35 37 33 52 26 11 16 28 37 41
2024/20251.611 4 103 66 74 206 51 60 114 143 77 300 413
2025/20261.429 327 493 609 0 0 0 0 0 0 0 0 0
Totale 8.728